La financiarización de las grandes empresas farmacéuticas

Autores/as

DOI:

https://doi.org/10.3989/ris.2020.78.4.m20.006

Palabras clave:

Finanzas corporativas, Activos intangibles, Monopolio, Valor del accionista, Thorstein Veblen

Resumen


En este artículo, empleamos un marco Vebleniano para analizar tres dimensiones de la financiarización corporativa: la expansión del balance, la creciente importancia de los activos intangibles y los crecientes niveles de pagos financieros. Nuestro enfoque es el sector farmacéutico, que está fuertemente dominado por un puñado de grandes corporaciones conocidas como Big Pharma. En nuestro análisis empírico de las cuentas financieras de 27 de las mayores corporaciones farmacéuticas mundiales para los años 2000-2018, encontramos evidencia de un cambio en el modelo de negocio de uno centrado en la capacidad productiva (reflejado por capital fijo e I + D) a uno centrado en activos intangibles (reflejados en patentes, marcas y fondo de comercio). El modus operandi de las grandes farmacéuticas se asemeja cada vez más al de un fondo de capital privado que genera rendimientos para los accionistas respaldados por el conocimiento monopolizado a través de los derechos de propiedad intelectual, el potencial de ganancias futuras capitalizadas y el aumento de la carga de la deuda. Nuestro marco facilita el estudio de los diferentes elementos de la financiarización y cómo co-evolucionan (o no) a lo largo del tiempo, dentro y entre industrias, y entre países o regiones globales.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Aalbers, M. B. 2019. “Financialization”. In The International Encyclopedia of Geography: People, the Earth, Environment, and Technology, edited by D. Richardson, N. Castree, M. F. Goodchild, A. Kobayashi, W. Liu, and R. A. Marston, 2nd ed. Oxford: Wiley.

Andersson, T., P. Gleadle, C. Haslam, and N. Tsitsianis. 2010. “Bio-Pharma: A Financialized Business Model”. Critical Perspectives on Accounting 21 (7): 631–641.

Andersson, T., C. Haslam and E. Lee. 2006. “Financialized Accounts: Restructuring and Return on Capital Employed in the S&P 500”. Accounting Forum 30 (1): 21–41.

Baranes, A. I. 2016. ‘An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets’. PhD Thesis, Kansas City: University of Missouri.

Baranes, A. I. 2017. “Financialization in the American Pharmaceutical Industry: A Veblenian Approach”. Journal of Economic Issues 51 (2): 351–358.

Baranes, A. I., and E. R. Hake. 2018. “The Institutionalist Theory of Capital in the Modern Business Enterprise: Appropriation and Financialization”. Journal of Economic Issues 52 (2): 430–437.

Bates, T. W., K. M. Kahle, and R. M. Stulz. 2009. “Why Do U.S. Firms Hold So Much More Cash than They Used To?” The Journal of Finance 64 (5): 1985–2021.

Bryan, D., M. Rafferty, and D. Wigan. 2017. “Capital Unchained: Finance, Intangible Assets and the Double Life of Capital in the Offshore World”. Review of International Political Economy 24 (1): 56–86.

Christophers, B. 2019. “The Rentierization of the United Kingdom Economy”. Environment and Planning A: Economy and Space, September, 0308518X1987300.

Crotty, J. 2003. “The Neoliberal Paradox: The Impact of Destructive Product Market Competition and Impatient Finance on Nonfinancial Corporations in the Neoliberal Era”. Review of Radical Political Economics 35 (3): 271–279.

Davis, L. E. 2016. “Identifying the “Financialization” of the Nonfinancial Corporation in the U.S. Economy: A Decomposition of Firm-Level Balance Sheets”. Journal of Post Keynesian Economics 39 (1): 115–141.

Davis, L. E. 2018. “Financialization, Shareholder Orientation and the Cash Holdings of US Corporations”. Review of Political Economy 30 (1): 1–27.

Durand, C. 2017. Fictitious Capital: How Finance Is Appropriating Our Future. London, New York: Verso.

Durand, C., and W. Milberg. 2020. “Intellectual monopoly in global value chains”. Review of International Political Economy 27(2): 404-429.

Fernandez, R., P. Bortz, and N. Zeolla. 2018. “The Politics of Quantitative Easing. A Critical Assessment of the Harmful Impact of European Monetary Policy on Developing Countries”. Amsterdam: SOMO. https://www. somo.nl/the-politics-of-quantitative-easing/

Fernandez, R., and R. Hendrikse. 2015. “Rich Corporations, Poor Societies: The Financialisation of Apple”. Amsterdam: SOMO. https://www.somo.nl/wp-content/uploads/2015/10/Rich-corporations-poor-societies.pdf

Fiebiger, B. 2016. “Rethinking the Financialisation of Non-Financial Corporations: A Reappraisal of US Empirical Data”. Review of Political Economy 28 (3): 354–379.

Froud, J., C. Haslam, S. Johal, and K. Williams. 2000. “Shareholder Value and Financialization: Consultancy Promises, Management Moves”. Economy and Society 29 (1): 80–110.

Froud, J., S. Johal, A. Leaver, and K. Williams, eds. 2006. Financialization and Strategy: Narrative and Numbers. London, New York: Routledge.

Hofman, A., and M. B. Aalbers. 2019. A finance- and real estate-driven regime in the United Kingdom. Geoforum 100: 89-100.

Hudson, M. 2015. Killing the Host. How Financial Parasites and Debt Bondage Destroy the Global Economy. Dresden: ISLET.

International Monetary Fund. 2006. World Economic Outlook April 2006. Globalization and Inflation. World Economic Outlook 2006, April. Washington, DC: International Monetary Fund.

International Monetary Fund. 2019. Global Financial Stability Report: Lower for Longer. Washington, DC: International Monetary Fund. https://www.imf.org/en/Publications/GFSR/Issues/2019/10/01/global-financial-stability-report-october-2019.

Ireland, P. 2009. “Financialization and Corporate Governance”. Northern Ireland Legal Quarterly 60 (1): 1–34.

Jo, T.-H., and J. F. Henry. 2015. “The Business Enterprise in the Age of Money Manager Capitalism”. Journal of Economic Issues 49 (1): 23–46.

Kaltenbrunner, A. 2018. “The Financialisation of Non-Financial Corporations in Brazil”. In Debt Vulnerabilities in Developing Countries: A New Debt Trap? Volume I: Regional and Thematic Analyses, edited by UNCTAD, 53–71. New York, Geneva: United Nations. https://unctad.org/ en/PublicationsLibrary/gdsmdp2017d4v1_en.pdf

Karwowski, E., and E. Stockhammer. 2017. “Financialisation in Emerging Economies: A Systematic Overview and Comparison with Anglo-Saxon Economies”. Economic and Political Studies 5 (1): 60–86.

Kliman, A., and S. D. Williams. 2015. “Why “financialisation” Hasn’t Depressed US Productive Investment”. Cambridge Journal of Economics 39 (1): 67–92.

Krippner, G. R. 2005. “The Financialization of the American Economy”. Socio-Economic Review 3 (2): 173–208.

Lapavitsas, C. 2013. Profiting Without Producing. How Finance Exploits Us All. London, New York: Verso.

Lapavitsas, C., and J. Powell. 2013. “Financialisation Varied: A Comparative Analysis of Advanced Economies”. Cambridge Journal of Regions, Economy and Society 6 (3): 359–379.

Lazonick, W. 2013. “The Financialization of the U.S. Corporation: What Has Been Lost, and How It Can Be Regained”. Seattle University Law Review 36 (2): 857–909.

Lazonick, W. 2014. “Profits Without Prosperity”. Harvard Business Review, 1 September 2014. https://hbr. org/2014/09/profits-without-prosperity

Lazonick, W., and M. O’Sullivan. 2000. “Maximizing Shareholder Value: A New Ideology for Corporate Governance”. Economy and Society 29 (1): 13–35.

Lazonick, W, and Ö. Tulum. 2011. ‘US Biopharmaceutical Finance and the Sustainability of the Biotech Business Model’. Research Policy 40 (9): 1170–1187.

Leaver, A. 2018. “Intangible Concerns: Goodwill and the Risk of pro-Cyclicality in Corporate America”. SPERI. 18 June 2018. http://speri.dept.shef.ac.uk/2018/06/19/ intangible-concerns-goodwill-and-the-risk-of-pro-cyclicality-in-corporate-america/

Lee, R., G. L. Clark, J. Pollard, and A. Leyshon. 2009. “The Remit of Financial Geography - before and after the Crisis”. Journal of Economic Geography 9 (5): 723– 747.

Montalban, M., and M. E. Sakinç. 2013. “Financialization and Productive Models in the Pharmaceutical Industry”. Industrial and Corporate Change 22 (4): 981–1030.

Orhangazi, Ö. 2008. “Financialisation and Capital Accumulation in the Non-Financial Corporate Sector: A Theoretical and Empirical Investigation on the US Economy: 1973-2003”. Cambridge Journal of Economics 32 (6): 863–886.

Orhangazi, Ö. 2018. “The Role of Intangible Assets in Explaining the Investment–Profit Puzzle”. Cambridge Journal of Economics 43 (5): 1251–1286.

Perry, J., and A. Nölke. 2006. “The Political Economy of International Accounting Standards”. Review of International Political Economy 13 (4): 559–86.

Rabinovich, J. 2019. “The Financialization of the Non-financial Corporation. A Critique to the Financial Turn of Accumulation Hypothesis”. Metroeconomica, 70 (4): 738- 775.

Rikap, C. 2019. “Asymmetric Power of the Core: Technological Cooperation and Technological Competition in the Transnational Innovation Networks of Big Pharma”. Review of International Political Economy 26 (5): 987–1021.

Serfati, C. 2008. “Financial Dimensions of Transnational Corporations, Global Value Chain and Technological Innovation”. Journal of Innovation Economics 2 (2): 35-61.

Serfati, C. 2011. “Transnational Corporations as Financial Groups”. Work Organisation, Labour & Globalisation 5 (1): 10-38.

Statista. 2019. “Global Pharmaceutical Industry”. Dossier. https://www.statista.com/study/10642/global-pharmaceutical-industry-statista-dossier/

Stockhammer, E. 2004. “Financialisation and the Slowdown of Accumulation”. Cambridge Journal of Economics 28 (5): 719–41.

Sweezy, P. M. 1958. “Veblen’s Critique of the American Economy”. The American Economic Review 48 (2): 21–29.

Tomaskovic-Devey, D., Ken-Hou L. and N. Meyers. 2015. “Did Financialization Reduce Economic Growth?” Socio-Economic Review 13 (3): 525–548.

Tori, D., and Ö. Onaran. 2018a. “The Effects of Financialization on Investment: Evidence from Firm-Level Data for the UK”. Cambridge Journal of Economics 42 (5): 1393–1416.

Tori, D., and Ö. Onaran. 2018b. “Financialization, Financial Development and Investment. Evidence from European Non-Financial Corporations”. Socio-Economic Review, mwy044.

UNCTAD. 2017. “Market Power and Inequality: The Revenge of the Rentiers”. Pp. 119-145 in Trade and Development Report 2017. New York, Geneva: UN.

UNCTAD. 2018. “Corporate Rent-Seeking, Market Power and Inequality: Time for a Multilateral Trust Buster?” UNCTAD Policy Brief 66.

Veblen, T. 1908a. “On the Nature of Capital”. The Quarterly Journal of Economics 22: 517–42.

Veblen, T. 1908b. “On the Nature of Capital: Investment, Intangible Assets, and the Pecuniary Magnate”. The Quarterly Journal of Economics 23: 104–136.

Veblen, T. 1958 [1904]. The Theory of Business Enterprise. New York: Mentor.

Waller, W. T. 1982. “The Evolution of the Veblenian Dichotomy: Veblen, Hamilton, Ayres, and Foster”. Journal of Economic Issues 16 (3): 757–771.

Zeller, Ch. 2007. “From the Gene to the Globe: Extracting Rents Based on Intellectual Property Monopolies”. Review of International Political Economy 15 (1): 86–115.

Zwan, N. van der. 2014. “Making Sense of Financialization”. Socio-Economic Review 12 (1): 99–129.

Publicado

2020-12-15

Cómo citar

Klinge, T. J. ., Fernandez, R. ., & Aalbers, M. B. . (2020). La financiarización de las grandes empresas farmacéuticas. Revista Internacional De Sociología, 78(4), e174. https://doi.org/10.3989/ris.2020.78.4.m20.006

Número

Sección

Artículos